Generated by AI
Summary of Sep 29's posts. Generated by AI.
Summary of Sep 23's posts. Generated by AI.
Summary of Sep 29's posts. Generated by AI.
Investors talking about IMCC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
IM Cannabis Corp. is an international medical cannabis company focused on importing, distributing, and selling cannabis-based products for medical patients in Israel and Germany. The company offers dried flower and full-spectrum cannabis extract products under brands including IMC, BLKMT, and LOT420, with a business model centered on regulated medical markets and pharmacy-based supply chains. Its operations include product sourcing, quality control, and market-specific distribution across Europe and the Middle East, supporting physicians, pharmacies, and patients who rely on standardized cannabis formulations. IM Cannabis Corp. also maintains an online and retail presence tied to its medical cannabis ecosystem, reinforcing its role as a specialized supplier within the healthcare and life sciences sectors. Headquartered in Kibbutz Glil-Yam, Israel, the company remains positioned as a focused participant in the growing regulated medical cannabis market.
Website3606 – 833 Seymour Street
Vancouver, BC, V6B 0G4
Canada
The latest articles about IMCC.
Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.
VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026/ PRNewswire/-- IM Cannabis Corp., today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 among the Company, Slil.com Holding Ltd. and I.M.C....